Quality of Life Among Women Treated for Breast Cancer: A Survey of Three Procedures in Mexico

Cortés-Flores, Ana Olivia; Morgan-Villela, Gilberto; Valle, Carlos; Jiménez-Tornero, Jorge; Juárez-Uzeta, Ernesto; Urias-Valdez, Diana Paola; Garcia-González, Luis-Alberto; Chávez-Tostado, Mariana; Macías-Amezcua, Michel Dassaejv; García-Rentería, Jesús; González-Ojeda, Alejandro

doi:10.1007/s00266-014-0384-5

Cited by 13 publications

(18 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The found results are consistent with the results of other research that also showed that mastectomy and non-breast reconstruction, portray the lowest scores for quality of life [4,8,10]. In fact, breast reconstruction has been incorporated into a better concept of quality of life, integrity and preservation of self-image [12,13].…”

Section: Discussionsupporting

confidence: 91%

“…The best quality of life was detected in the emotional domain. It is noticed that the studies have shown conflicting results [10,11]. In this situation, reaffirms the need and relevance of assessing the individual thinking in one and not the collectivity because the being must be evaluated in the context in which is inserted, taking into account their needs, the variables involved in their lives and their daily lives.…”

Section: Discussionmentioning

confidence: 83%

“…In the performed study, women with surgery time of less than 1 year, had a more impaired quality of life, especially in the functional aspect. In performed studies, it has been perceived that breast cancer brings several implications in the woman's life, who suffers from the feeling of mutilation and loss, and still suffer with low self-esteem and changes in their body image [8,9,10]. The more compromised quality of life among women with shorter surgery time must be probably by the fact that in the early days of surgery, the woman suffers from the pain of surgery and the loss of a part of their body.…”

Section: Discussionmentioning

confidence: 99%

“…Despite major advances, therapy is still aggressive and has many negative effects on the quality of life of women, and commits their physical and emotional functions, body image, its prospects [7,8,9], their everyday life and social activities [9], significantly affecting the very quality of life [10,11,12]. The local therapy treats the tumor, is performed through adjuvant surgery, is performed after the patient is subjected (chemotherapy, hormonal therapy or targeted therapy) to prevent the recurrence of the disease and neoadjuvant is performed to allow a less invasive surgery, such as radiotherapy and chemotherapy [12].…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Repercussions of therapy for breast cancer on woman’s quality of life

et al. 2016

View full text Add to dashboard Cite

Objective: Despite the great advances, the treatment of breast cancer is still aggressive and has implications that affect the quality of life of women, so we intend to evaluate the treatment repercussions for breast cancer in the quality of life of women.Methods: This is a cross-sectional study, performed in a philanthropic hospital with a sample of 170 women. A characterization instrument of the subject and the Functional Assessment of Cancer Therapy-Breast was used to evaluate the quality of life. The Shapiro-Wilk, Kruskal Wallis H, Linear Correlation of Pearson and Spearman tests were used for analysis. The error margin was 5% and confidence interval 95%.Results: Among the therapies, surgery was the one that most affected the quality of life of women, and the Functional Domain, the more committed. Conclusion:The assistance to woman's health should be of excellence and focus on the best quality of life of women.

show abstract

Section: Discussionsupporting

confidence: 91%

Section: Discussionmentioning

confidence: 83%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Repercussions of therapy for breast cancer on woman’s quality of life

et al. 2016

View full text Add to dashboard Cite

show abstract

“…The same method was used to derive the utility score for neutropenia, but using non-small-cell-lung-cancer literature as a proxy [ 21 ] owing to absence of more specific data in the breast cancer literature. Utility scores for both surgery types were assumed equal [ 22 – 24 ]. No literature on the effect of monitoring on HRQoL was found, thus it was assumed unaltered.…”

Section: Methodsmentioning

confidence: 99%

Exploratory Cost-Effectiveness Analysis of Response-Guided Neoadjuvant Chemotherapy for Hormone Positive Breast Cancer Patients

et al. 2016

View full text Add to dashboard Cite

PurposeGuiding response to neoadjuvant chemotherapy (guided-NACT) allows for an adaptative treatment approach likely to improve breast cancer survival. In this study, our primary aim is to explore the expected cost-effectiveness of guided-NACT using as a case study the first randomized controlled trial that demonstrated effectiveness (GeparTrio trial).Materials and MethodsAs effectiveness was shown in hormone-receptor positive (HR+) early breast cancers (EBC), our decision model compared the health-economic outcomes of treating a cohort of such women with guided-NACT to conventional-NACT using clinical input data from the GeparTrio trial. The expected cost-effectiveness and the uncertainty around this estimate were estimated via probabilistic cost-effectiveness analysis (CEA), from a Dutch societal perspective over a 5-year time-horizon.ResultsOur exploratory CEA predicted that guided-NACT as proposed by the GeparTrio, costs additional €110, but results in 0.014 QALYs gained per patient. This scenario of guided-NACT was considered cost-effective at any willingness to pay per additional QALY. At the prevailing Dutch willingness to pay threshold (€80.000/QALY) cost-effectiveness was expected with 78% certainty.ConclusionThis exploratory CEA indicated that guided-NACT (as proposed by the GeparTrio trial) is likely cost-effective in treating HR+ EBC women. While prospective validation of the GeparTrio findings is advisable from a clinical perspective, early CEAs can be used to prioritize further research from a broader health economic perspective, by identifying which parameters contribute most to current decision uncertainty. Furthermore, their use can be extended to explore the expected cost-effectiveness of alternative guided-NACT scenarios that combine the use of promising imaging techniques together with personalized treatments.

show abstract

Health-Related Quality of Life in Patients with Breast Cancer in Latin America and the Caribbean: A Systematic Review and Meta-Analysis

et al. 2021

View full text Add to dashboard Cite

Background and Objectives. Breast cancer (BC) is the most common cancer in women. It imposes a huge disease burden and a significant impact on health-related quality of life (HRQoL). Our study focused on HRQoL of patients with BC in Latin America and the Caribbean (LAC). We conducted a systematic review to identify relevant articles published between 2008 and August 2018. We conducted several meta-analyses and subgroup analyses by country, disease stage, and instrument used (Prospective Register Of Systematic Reviews registration number: CRD42018106835). Results. From 2,265 initial references, we finally included 75 articles (8,806 participants) that assessed HRQoL. The European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire C30 and B23 modules (34 studies; 8 countries; 4,866 participants) were the most used instruments, followed by the Short Form 36-item, the abbreviated version of the World Health Organization Quality of Life instrument, and the Functional Assessment of Cancer Therapy-Breast instrument. Only four studies reported specific HRQoL data of patients with metastatic disease. Half the studies were rated as having moderate quality (38/75), and 38% (29/75) as high quality. We identified substantial heterogeneity. As expected, the metaanalyses revealed that patients with metastatic disease reported lower HRQoL values and high symptom burden compared with patients at earlier stages. Similar results can be observed when we compared patients with early breast cancer in active treatment phases versus those in follow-up. Conclusion. This study provides a synthesis of breast cancer HRQoL reported in LAC and exposes existing evidence gaps. Patients with BC in active treatment or with metastatic disease had worse HRQoL compared with survivors during the follow-up period. The Oncologist 2021;9999:• • Implications for Practice: This systematic review study provides an exhaustive synthesis of breast cancer health-related quality of life in women in the Latin American and Caribbean region. Patients with breast cancer in active treatment or with metastatic disease had worse health-related quality of life compared with survivors during the different follow-up periods. This study also shows important evidence and methods gaps that can help inform future research.

show abstract

Quality of Life Among Women Treated for Breast Cancer: A Survey of Three Procedures in Mexico

Abstract: The quadrantectomy procedure had better acceptance, but the overall health status did not differ between the groups. The overall health status was lower among the women older than 50 years who had received a mastectomy without reconstruction.

Cited by 13 publications

References 31 publications

Repercussions of therapy for breast cancer on woman’s quality of life

Repercussions of therapy for breast cancer on woman’s quality of life

Exploratory Cost-Effectiveness Analysis of Response-Guided Neoadjuvant Chemotherapy for Hormone Positive Breast Cancer Patients

Health-Related Quality of Life in Patients with Breast Cancer in Latin America and the Caribbean: A Systematic Review and Meta-Analysis

Contact Info

Product

Resources

About